Result: The positive rate of anti-NMDAR antibodies was 80%, AMPAR1/R2 was 10%, GABABR was 10%, and there have been no positive cases with anti-LGI1, CASPR2 receptor antibodies and simultaneously positive for many different types of antibodies.